Animal model studies have shown that PGE2 and its analog have protective effects against bleomycin-induced pulmonary fibrosis (16, 17); in contrast, a lack of COX-2 and COX-2-derived PGE2 promotes fibrosis (18, 19). Here, PTGS2 is linked to pulmonary fibrosis.